API Manufacturing & Services
Total Trials
1
As Lead Sponsor
0
As Collaborator
Total Enrollment
215
NCT01080066
A Post Marketing Surveillance Study of Cetuximab in Patients With Squamous Cell Carcinoma of Head and Neck (SCCHN)
Phase: N/A
Role: Collaborator
Start: Sep 30, 2010
Completion: Dec 31, 2013
Loading map...